Kusajili – Clinical trials directory

Result of your search per sponsor: Pfizer Hellas AE

Woman and Man Max 99 years
Pfizer Hellas AE Update Il y a 4 ans

A SIXTEEN-WEEK, MULTI-CENTER, OPEN-LABEL STUDY EVALUATING THE SAFETY, TOLERABILITY, AND EFFICACY OF SWITCHING FROM QUETIAPINE TO ZIPRASIDONE IN SUBJECTS DIAGNOSED WITH SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER The primary objective of this study is to evaluate change in weight as a result of switching to ziprasidone, in subjects who have failed to achieve a satisfactory clinical response to quetiapine due t...

Country None
organs None
Specialty None

unknown

More information